BindingDB logo
myBDB logout

Patent code US8841453

Compile Data Set for Download or QSAR
Found 36 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Cholinesterase


(Homo sapiens (Human))		BDBM132084
PNG
(US8841453, 15)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C38H51N5O3/c1-28(44)39-25-22-29-27-42-34-21-20-30(26-33(29)34)46-38(45)41-24-15-9-7-5-3-2-4-6-8-14-23-40-37-31-16-10-12-18-35(31)43-36-19-13-11-17-32(36)37/h10,12,16,18,20-21,26-27,42H,2-9,11,13-15,17,19,22-25H2,1H3,(H,39,44)(H,40,43)(H,41,45)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.240n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132080
PNG
(US8841453, 11)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C34H43N5O3/c1-24(40)35-21-18-25-23-38-30-17-16-26(22-29(25)30)42-34(41)37-20-11-5-3-2-4-10-19-36-33-27-12-6-8-14-31(27)39-32-15-9-7-13-28(32)33/h6,8,12,14,16-17,22-23,38H,2-5,7,9-11,13,15,18-21H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.25n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132071
PNG
(US8841453, 1)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C33H41N5O3/c1-23(39)34-20-17-24-22-37-29-16-15-25(21-28(24)29)41-33(40)36-19-10-4-2-3-9-18-35-32-26-11-5-7-13-30(26)38-31-14-8-6-12-27(31)32/h5,7,11,13,15-16,21-22,37H,2-4,6,8-10,12,14,17-20H2,1H3,(H,34,39)(H,35,38)(H,36,40)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.25n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132083
PNG
(US8841453, 14)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C36H47N5O3/c1-26(42)37-23-20-27-25-40-32-19-18-28(24-31(27)32)44-36(43)39-22-13-7-5-3-2-4-6-12-21-38-35-29-14-8-10-16-33(29)41-34-17-11-9-15-30(34)35/h8,10,14,16,18-19,24-25,40H,2-7,9,11-13,15,17,20-23H2,1H3,(H,37,42)(H,38,41)(H,39,43)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.280n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132074
PNG
(US8841453, 4)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C33H40ClN5O3/c1-22(40)35-18-15-23-21-38-29-14-12-25(20-28(23)29)42-33(41)37-17-8-4-2-3-7-16-36-32-26-9-5-6-10-30(26)39-31-19-24(34)11-13-27(31)32/h11-14,19-21,38H,2-10,15-18H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.380n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132088
PNG
(US8841453, 17)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C38H50ClN5O3/c1-27(45)40-23-20-28-26-43-34-19-17-30(25-32(28)34)47-38(46)42-22-13-9-7-5-3-2-4-6-8-12-21-41-37-31-14-10-11-15-35(31)44-36-18-16-29(39)24-33(36)37/h16-19,24-26,43H,2-15,20-23H2,1H3,(H,40,45)(H,41,44)(H,42,46)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.780n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132081
PNG
(US8841453, 12)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C33H40ClN5O3/c1-22(40)35-18-15-23-21-38-29-14-12-25(20-27(23)29)42-33(41)37-17-8-4-2-3-7-16-36-32-26-9-5-6-10-30(26)39-31-13-11-24(34)19-28(31)32/h11-14,19-21,38H,2-10,15-18H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 0.880n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132083
PNG
(US8841453, 14)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C36H47N5O3/c1-26(42)37-23-20-27-25-40-32-19-18-28(24-31(27)32)44-36(43)39-22-13-7-5-3-2-4-6-12-21-38-35-29-14-8-10-16-33(29)41-34-17-11-9-15-30(34)35/h8,10,14,16,18-19,24-25,40H,2-7,9,11-13,15,17,20-23H2,1H3,(H,37,42)(H,38,41)(H,39,43)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.18n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132086
PNG
(US8841453, 18)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C36H46ClN5O3/c1-25(43)38-21-18-26-24-41-32-17-15-28(23-31(26)32)45-36(44)40-20-11-7-5-3-2-4-6-10-19-39-35-29-12-8-9-13-33(29)42-34-22-27(37)14-16-30(34)35/h14-17,22-24,41H,2-13,18-21H2,1H3,(H,38,43)(H,39,42)(H,40,44)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.20n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132087
PNG
(US8841453, 19)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C38H50ClN5O3/c1-27(45)40-23-20-28-26-43-34-19-17-30(25-33(28)34)47-38(46)42-22-13-9-7-5-3-2-4-6-8-12-21-41-37-31-14-10-11-15-35(31)44-36-24-29(39)16-18-32(36)37/h16-19,24-26,43H,2-15,20-23H2,1H3,(H,40,45)(H,41,44)(H,42,46)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.31n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132085
PNG
(US8841453, 16)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C36H46ClN5O3/c1-25(43)38-21-18-26-24-41-32-17-15-28(23-30(26)32)45-36(44)40-20-11-7-5-3-2-4-6-10-19-39-35-29-12-8-9-13-33(29)42-34-16-14-27(37)22-31(34)35/h14-17,22-24,41H,2-13,18-21H2,1H3,(H,38,43)(H,39,42)(H,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.43n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132085
PNG
(US8841453, 16)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C36H46ClN5O3/c1-25(43)38-21-18-26-24-41-32-17-15-28(23-30(26)32)45-36(44)40-20-11-7-5-3-2-4-6-10-19-39-35-29-12-8-9-13-33(29)42-34-16-14-27(37)22-31(34)35/h14-17,22-24,41H,2-13,18-21H2,1H3,(H,38,43)(H,39,42)(H,40,44)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.64n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132073
PNG
(US8841453, 3)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C32H39N5O3/c1-22(38)33-19-16-23-21-36-28-15-14-24(20-27(23)28)40-32(39)35-18-9-3-2-8-17-34-31-25-10-4-6-12-29(25)37-30-13-7-5-11-26(30)31/h4,6,10,12,14-15,20-21,36H,2-3,5,7-9,11,13,16-19H2,1H3,(H,33,38)(H,34,37)(H,35,39)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 2.04n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132079
PNG
(US8841453, 10)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C31H37N5O3/c1-21(37)32-18-15-22-20-35-27-14-13-23(19-26(22)27)39-31(38)34-17-8-2-7-16-33-30-24-9-3-5-11-28(24)36-29-12-6-4-10-25(29)30/h3,5,9,11,13-14,19-20,35H,2,4,6-8,10,12,15-18H2,1H3,(H,32,37)(H,33,36)(H,34,38)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 2.07n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132076
PNG
(US8841453, 7)
Show SMILES CC(=O)O[C@@]12CCN([C@@H]1N(C(C)=O)c1ccc(OC(=O)NCCCCCCNc3c4CCCCc4nc4ccccc34)cc21)C(C)=O |r|
Show InChI InChI=1S/C36H43N5O6/c1-23(42)40-21-18-36(47-25(3)44)29-22-26(16-17-32(29)41(24(2)43)34(36)40)46-35(45)38-20-11-5-4-10-19-37-33-27-12-6-8-14-30(27)39-31-15-9-7-13-28(31)33/h6,8,12,14,16-17,22,34H,4-5,7,9-11,13,15,18-21H2,1-3H3,(H,37,39)(H,38,45)/t34-,36-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 3.15n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132084
PNG
(US8841453, 15)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C38H51N5O3/c1-28(44)39-25-22-29-27-42-34-21-20-30(26-33(29)34)46-38(45)41-24-15-9-7-5-3-2-4-6-8-14-23-40-37-31-16-10-12-18-35(31)43-36-19-13-11-17-32(36)37/h10,12,16,18,20-21,26-27,42H,2-9,11,13-15,17,19,22-25H2,1H3,(H,39,44)(H,40,43)(H,41,45)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 3.80n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132072
PNG
(US8841453, 2)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C28H31N5O3/c1-18(34)29-13-12-19-17-32-24-11-10-20(16-23(19)24)36-28(35)31-15-14-30-27-21-6-2-4-8-25(21)33-26-9-5-3-7-22(26)27/h2,4,6,8,10-11,16-17,32H,3,5,7,9,12-15H2,1H3,(H,29,34)(H,30,33)(H,31,35)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 4.28n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132080
PNG
(US8841453, 11)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C34H43N5O3/c1-24(40)35-21-18-25-23-38-30-17-16-26(22-29(25)30)42-34(41)37-20-11-5-3-2-4-10-19-36-33-27-12-6-8-14-31(27)39-32-15-9-7-13-28(32)33/h6,8,12,14,16-17,22-23,38H,2-5,7,9-11,13,15,18-21H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 4.61n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132088
PNG
(US8841453, 17)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C38H50ClN5O3/c1-27(45)40-23-20-28-26-43-34-19-17-30(25-32(28)34)47-38(46)42-22-13-9-7-5-3-2-4-6-8-12-21-41-37-31-14-10-11-15-35(31)44-36-18-16-29(39)24-33(36)37/h16-19,24-26,43H,2-15,20-23H2,1H3,(H,40,45)(H,41,44)(H,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 7n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132074
PNG
(US8841453, 4)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C33H40ClN5O3/c1-22(40)35-18-15-23-21-38-29-14-12-25(20-28(23)29)42-33(41)37-17-8-4-2-3-7-16-36-32-26-9-5-6-10-30(26)39-31-19-24(34)11-13-27(31)32/h11-14,19-21,38H,2-10,15-18H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 7.70n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132086
PNG
(US8841453, 18)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C36H46ClN5O3/c1-25(43)38-21-18-26-24-41-32-17-15-28(23-31(26)32)45-36(44)40-20-11-7-5-3-2-4-6-10-19-39-35-29-12-8-9-13-33(29)42-34-22-27(37)14-16-30(34)35/h14-17,22-24,41H,2-13,18-21H2,1H3,(H,38,43)(H,39,42)(H,40,44)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 8.10n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132082
PNG
(US8841453, 13)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C28H30ClN5O3/c1-17(35)30-11-10-18-16-33-24-9-7-20(15-22(18)24)37-28(36)32-13-12-31-27-21-4-2-3-5-25(21)34-26-8-6-19(29)14-23(26)27/h6-9,14-16,33H,2-5,10-13H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 8.20n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132078
PNG
(US8841453, 9)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C30H35N5O3/c1-20(36)31-17-14-21-19-34-26-13-12-22(18-25(21)26)38-30(37)33-16-7-6-15-32-29-23-8-2-4-10-27(23)35-28-11-5-3-9-24(28)29/h2,4,8,10,12-13,18-19,34H,3,5-7,9,11,14-17H2,1H3,(H,31,36)(H,32,35)(H,33,37)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 15.5n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132075
PNG
(US8841453, 5)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C28H30ClN5O3/c1-17(35)30-11-10-18-16-33-24-9-7-20(15-23(18)24)37-28(36)32-13-12-31-27-21-4-2-3-5-25(21)34-26-14-19(29)6-8-22(26)27/h6-9,14-16,33H,2-5,10-13H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 20.1n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132087
PNG
(US8841453, 19)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCCCCCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C38H50ClN5O3/c1-27(45)40-23-20-28-26-43-34-19-17-30(25-33(28)34)47-38(46)42-22-13-9-7-5-3-2-4-6-8-12-21-41-37-31-14-10-11-15-35(31)44-36-24-29(39)16-18-32(36)37/h16-19,24-26,43H,2-15,20-23H2,1H3,(H,40,45)(H,41,44)(H,42,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 25.6n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132071
PNG
(US8841453, 1)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C33H41N5O3/c1-23(39)34-20-17-24-22-37-29-16-15-25(21-28(24)29)41-33(40)36-19-10-4-2-3-9-18-35-32-26-11-5-7-13-30(26)38-31-14-8-6-12-27(31)32/h5,7,11,13,15-16,21-22,37H,2-4,6,8-10,12,14,17-20H2,1H3,(H,34,39)(H,35,38)(H,36,40)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 33.8n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132075
PNG
(US8841453, 5)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4cc(Cl)ccc34)cc12
Show InChI InChI=1S/C28H30ClN5O3/c1-17(35)30-11-10-18-16-33-24-9-7-20(15-23(18)24)37-28(36)32-13-12-31-27-21-4-2-3-5-25(21)34-26-14-19(29)6-8-22(26)27/h6-9,14-16,33H,2-5,10-13H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 34.5n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132076
PNG
(US8841453, 7)
Show SMILES CC(=O)O[C@@]12CCN([C@@H]1N(C(C)=O)c1ccc(OC(=O)NCCCCCCNc3c4CCCCc4nc4ccccc34)cc21)C(C)=O |r|
Show InChI InChI=1S/C36H43N5O6/c1-23(42)40-21-18-36(47-25(3)44)29-22-26(16-17-32(29)41(24(2)43)34(36)40)46-35(45)38-20-11-5-4-10-19-37-33-27-12-6-8-14-30(27)39-31-15-9-7-13-28(31)33/h6,8,12,14,16-17,22,34H,4-5,7,9-11,13,15,18-21H2,1-3H3,(H,37,39)(H,38,45)/t34-,36-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 36.8n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132081
PNG
(US8841453, 12)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C33H40ClN5O3/c1-22(40)35-18-15-23-21-38-29-14-12-25(20-27(23)29)42-33(41)37-17-8-4-2-3-7-16-36-32-26-9-5-6-10-30(26)39-31-13-11-24(34)19-28(31)32/h11-14,19-21,38H,2-10,15-18H2,1H3,(H,35,40)(H,36,39)(H,37,41)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 39.9n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Cholinesterase


(Homo sapiens (Human))		BDBM132077
PNG
(US8841453, 8)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C29H33N5O3/c1-19(35)30-16-13-20-18-33-25-12-11-21(17-24(20)25)37-29(36)32-15-6-14-31-28-22-7-2-4-9-26(22)34-27-10-5-3-8-23(27)28/h2,4,7,9,11-12,17-18,33H,3,5-6,8,10,13-16H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 58.2n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132073
PNG
(US8841453, 3)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C32H39N5O3/c1-22(38)33-19-16-23-21-36-28-15-14-24(20-27(23)28)40-32(39)35-18-9-3-2-8-17-34-31-25-10-4-6-12-29(25)37-30-13-7-5-11-26(30)31/h4,6,10,12,14-15,20-21,36H,2-3,5,7-9,11,13,16-19H2,1H3,(H,33,38)(H,34,37)(H,35,39)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 178n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132079
PNG
(US8841453, 10)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C31H37N5O3/c1-21(37)32-18-15-22-20-35-27-14-13-23(19-26(22)27)39-31(38)34-17-8-2-7-16-33-30-24-9-3-5-11-28(24)36-29-12-6-4-10-25(29)30/h3,5,9,11,13-14,19-20,35H,2,4,6-8,10,12,15-18H2,1H3,(H,32,37)(H,33,36)(H,34,38)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 186n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132077
PNG
(US8841453, 8)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C29H33N5O3/c1-19(35)30-16-13-20-18-33-25-12-11-21(17-24(20)25)37-29(36)32-15-6-14-31-28-22-7-2-4-9-26(22)34-27-10-5-3-8-23(27)28/h2,4,7,9,11-12,17-18,33H,3,5-6,8,10,13-16H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 270n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132078
PNG
(US8841453, 9)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C30H35N5O3/c1-20(36)31-17-14-21-19-34-26-13-12-22(18-25(21)26)38-30(37)33-16-7-6-15-32-29-23-8-2-4-10-27(23)35-28-11-5-3-9-24(28)29/h2,4,8,10,12-13,18-19,34H,3,5-7,9,11,14-17H2,1H3,(H,31,36)(H,32,35)(H,33,37)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 378n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132072
PNG
(US8841453, 2)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4ccccc34)cc12
Show InChI InChI=1S/C28H31N5O3/c1-18(34)29-13-12-19-17-32-24-11-10-20(16-23(19)24)36-28(35)31-15-14-30-27-21-6-2-4-8-25(21)33-26-9-5-3-7-22(26)27/h2,4,6,8,10-11,16-17,32H,3,5,7,9,12-15H2,1H3,(H,29,34)(H,30,33)(H,31,35)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 1.10E+3n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
Acetylcholinesterase


(Homo sapiens (Human))		BDBM132082
PNG
(US8841453, 13)
Show SMILES CC(=O)NCCc1c[nH]c2ccc(OC(=O)NCCNc3c4CCCCc4nc4ccc(Cl)cc34)cc12
Show InChI InChI=1S/C28H30ClN5O3/c1-17(35)30-11-10-18-16-33-24-9-7-20(15-22(18)24)37-28(36)32-13-12-31-27-21-4-2-3-5-25(21)34-26-8-6-19(29)14-23(26)27/h6-9,14-16,33H,2-5,10-13H2,1H3,(H,30,35)(H,31,34)(H,32,36)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
n/an/a 3.28E+3n/an/an/an/an/an/a



Uniwersytet Warszawski; Centrum Medyczne Ksztalcenia Podyplomowego

US Patent


Assay Description
The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....

US Patent US8841453 (2014)


BindingDB Entry DOI: 10.7270/Q2W957VS
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%